US 8603978
Use of muramyl dipeptide (MDP) for treating inflammation
granted A61KA61K38/14A61P
Quick answer
US patent 8603978 (Use of muramyl dipeptide (MDP) for treating inflammation) held by The United States of America, as represented by the Secretary, Department of Health and Humand Services expires Mon Dec 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Humand Services
- Grant date
- Tue Dec 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K38/14, A61P, A61P1/04, A61P29/00